Dalton Venture and Portfolio Company Gestalt Technology Win Jazzyear and TMTpost Honors Including Annual Healthcare Best Investment Firm TOP30 and 2026H1 Biopharma Pioneer TOP20

道彤投资·August 21, 2026·3·8

Recently, Jazzyear unveiled its "2025-2026 China Tech Industry Investment Ranking" and TMTpost's "2026 H1 Pioneers List" was announced. **Dalton Venture** took home three awards across both rankings: "**2025-2026 Top 30 Best Healthcare Investment Firms**," "**2026 H1 Top 20 Pioneers in Biopharma**," and "**2026 H1 Top 10 Early-Stage Fundraising Pioneers**."

Honor Roll

Recently, Jazzyear unveiled its "2025-2026 China Tech Industry Investment Rankings" and TMTpost Venture Capital released its "2026 H1 Pioneer List." Dalton Venture claimed three awards across both rankings: "2025-2026 Top 30 Best Healthcare Investment Institutions," "2026 H1 Pioneer Top 20 in Biomedicine," and "2026 H1 Pioneer Top 10 Early-Stage Fundraising." Meanwhile, Dalton Venture portfolio company Gestalt Technology was named "2025-2026 Most Investable Healthcare Enterprise."

In 2026, China's tech investment landscape has entered a new period of turbulent waters. Artificial intelligence is rapidly reshaping industry maps, while hard tech remains the core focus of capital attention. At the same time, valuation frameworks, exit pathways, and models of industrial collaboration are undergoing profound shifts. Faced with accelerating technological iteration and an increasingly complex market environment, the key to investing is no longer simply chasing waves — it lies in riding out cycles and identifying genuine innovation backed by technical moats, commercial viability, and long-term value. Jazzyear recently published its "2025-2026 China Tech Industry Investment Rankings," which feature two categories: investment institutions & investors, and most investable enterprises. The list honors investment institutions, investors, and science-driven enterprises that have maintained professional judgment and held to long-term principles amid the rapids.

Recognized for its professional investment capabilities and strong track record, Dalton Venture was named to the "2025-2026 Top 30 Best Healthcare Investment Institutions." Gestalt Technology, a Dalton Venture portfolio company, made the "2025-2026 Most Investable Healthcare Enterprise" list.

Dalton Venture

2025-2026 Top 30 Best Healthcare Investment Institutions

Gestalt Technology

2025-2026 Most Investable Healthcare Enterprise

Additionally, TMTpost Venture Capital's "2026 H1 Pioneer List" was released with significant fanfare. Drawing on cross-verification across multiple public databases, the ranking recognized standout pioneer institutions in fundraising, investment, portfolio management, and exits during the first half of 2026, across ten hot sectors and the broader venture capital ecosystem. Dalton Venture earned two major honors: "2026 H1 Pioneer Top 10 Early-Stage Fundraising" and "2026 H1 Pioneer Top 20 in Biomedicine."

Dalton Venture

2026 H1 Pioneer Top 10 Early-Stage Fundraising

Dalton Venture

2026 H1 Pioneer Top 20 in Biomedicine

Like-minded and steady in our stride, Dalton Venture has grown into a leading domestic industry-focused investment institution, with deep systematic coverage of medical devices and equipment, brain-computer interfaces, bio-manufacturing, Embodied Artificial Intelligence, new materials, and other fields — delivering strong investment performance and numerous success stories. As an early-stage investor, we are gratified to see the value of our persistence pay off: multiple innovative technology bets from our earlier vintages are now bearing fruit, with several projects achieving domestic firsts in scientific and technological breakthroughs.

Going forward, Dalton Venture will continue to dig deep into our areas of expertise, moving forward with unwavering commitment to help more outstanding enterprises achieve leapfrog growth and create value for the advancement and development of the healthcare industry.